Method for applying electromagnetic pulse to oocytes cultured in vitro
By applying electromagnetic pulses to the oocyte cultured in vitro, the problem of low oocyte maturation rate is solved, the maturation and development ability of oocytes is significantly improved, the ovarian reserve function is improved, and the fertilization rate and blastocyst formation rate are improved. , improves oocyte index in elderly mice.
Patent Information
- Application Number
- CN202410730235.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-06
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-06-06
AI Technical Summary
The existing in vitro maturation technology of oocytes has the problems of low maturity rate and insufficient oocyte quality, which is difficult to effectively support the normal development of follicles, resulting in a decrease in ovarian reserve function and affecting women's reproductive ability.
Electromagnetic pulses with a frequency of 1 to 100Hz, an intensity of 1 to 10mT and a time of 5 to 20 minutes are used to treat oocytes cultured in vitro to improve their maturity and development ability.
It significantly improved the maturation and development ability of oocytes, improved the normal development of follicles, improved the ovarian reserve function, improved the fertilization rate and blastocyst formation rate, reduced the abnormal indicators of oocytes in older mice, and was close to young level of mice.
Smart Images

Figure CN118910035A_ABST
Abstract
Description
Technical Field
[0001] The present application belongs to the field of electromagnetic biology, and more specifically, relates to a method for applying electromagnetic pulses to oocytes cultured in vitro. Background Art
[0003] Exploring strategies for preserving female fertility is a hot topic and difficulty in the current reproductive field. On the one hand, the follicle pool of female patients with decreased fertility is exhausted, and there are only a very small number of resting primordial follicles in the ovarian cortex that cannot grow and develop naturally in vivo, but immature oocytes are difficult to mature in vitro. On the other hand, for young female cancer patients, freezing ovarian tissue before radiotherapy and chemotherapy, and obtaining immature oocytes for in vitro maturation (IVM) after thawing is the preferred method for preserving fertility. Improving the maturation rate of human oocytes in vitro culture, the quality of oocytes, and the subsequent embryonic development potential is an extremely critical link in improving the success rate of assisted reproductive outcomes.
[0004] The follicle is the core functional unit of the reproductive system of women of childbearing age. The ultimate goal of its development is to produce a fertile egg and complete the process of fertilization and embryonic development. In modern society, environmental factors, mental stress, etc. lead to premature depletion of the primordial follicle pool, which leads to premature decline of ovarian function, decreased ovarian reserve function, premature ovarian insufficiency, and ultimately premature ovarian failure, which seriously affects women's reproductive ability. The decline of fertility has brought a heavy physiological and psychological burden to the female population, so maintaining the normal development of follicles is particularly important for female reproduction. The development of follicles is a complex process involving multiple cells and multiple stages. Among them, granulosa cells and oocytes are important cells that constitute follicles. The formation of follicles requires close interaction between granulosa cells and oocytes. Oocytes and granulosa cells regulate the normal development of follicles through a series of autocrine or paracrine ways. In vitro maturation (IVM) of oocytes refers to obtaining immature oocytes from the ovaries and culturing them in vitro to make them mature and have the ability to fertilize and support embryonic development to full-term delivery. There are many problems with IVM technology at this stage, such as the lack of certain components in the in vitro culture medium, which is insufficient to support the development of oocytes. The existing methods for regulating the in vitro maturation and development ability of oocytes are very limited. Therefore, new treatment strategies are urgently needed. For the decline in ovarian reserve function caused by ovarian aging in older women, the main clinical solutions are currently promoting a healthy lifestyle, weight control, psychological counseling, contraception, and sexual health guidance. Although there are certain results, these improvement methods are difficult to achieve a definite therapeutic effect on the target organ, and only a very low proportion of patients achieve complete remission. Therefore, new treatment strategies are urgently needed.
[0005] In modern science, pulsed strong magnetic field is listed as one of the most important extreme conditions for scientific experiments. As the focus and frontier of strong magnetic field research, pulsed strong magnetic field is now receiving more and more attention. Pulsed electromagnetic field (PEMF) therapy has some potential advantages, including non-invasiveness, safety, and the possibility of being used in combination with other available therapies. PEMF is a magnetic field effect with pulsed intermittents generated by current passing through the Helmholtz coil. The PEMF device mainly consists of three parts. The first part is the signal generator, which can generate a voltage signal with a specific waveform and frequency; the second part is the signal amplifier, which can generate a current output to supply the electromagnetic field generator. Adjusting the output of the amplifier can change the magnitude of the field strength. The third part is the electromagnetic field generator, which is mainly composed of a coil. PEMF can act on biological systems non-invasively through capacitance and inductance. The former requires the relative electrodes to be placed around the tissue of interest and in direct contact with the skin, while the latter does not require contact with the skin. As a non-invasive physical intervention method, pulsed electromagnetic field was first used in the treatment of bone nonunion and delayed fracture healing. As a representative of low-frequency electromagnetic fields, low-frequency pulsed electromagnetic field (LF-PEMF) refers to a low-frequency, low-intensity magnetic field with a frequency of 1 to 100 Hz and a peak magnetic field of <10 mT. Pulsed electromagnetic field (PEMF) therapy has been proven to have some potential advantages, including non-invasiveness, safety, non-toxicity to non-cancerous cells, and the possibility of being used in combination with other available therapies. In recent years, it has been increasingly used in the treatment of neurological diseases and tumors, including skin cancer, breast cancer, prostate cancer, hepatocellular carcinoma, lung cancer, ovarian cancer, pancreatic cancer, bladder cancer, thyroid cancer, and colon cancer. Low-frequency pulsed strong magnetic fields can selectively kill tumor tissues and inhibit tumor growth, and regulate the immune system function of organisms. However, its effects on the reproductive system are still unclear. Summary of the invention
[0006] So can electromagnetic pulses be used to improve the in vitro maturation and development of oocytes so that they can play a longer role and have a good effect after being transplanted into the body? Through this application, we hope to regulate the in vitro maturation and development of oocytes through electromagnetic pulses, thereby providing a reference for clinical research on the reproductive system.
[0007] To achieve the above-mentioned purpose, the present application provides a method for applying electromagnetic pulses to oocytes cultured in vitro, comprising: applying electromagnetic pulses with a frequency of 1 to 100 Hz, an intensity of 1 to 10 mT, and a time of 5 to 20 min to the oocytes in the germinal vesicle stage.
[0008] Preferably, the culture density of the in vitro cultured oocytes is 300 to 600 oocytes / ml.
[0009] Preferably, the electromagnetic pulses are applied 1 to 10 times at an interval of 30 to 60 ms.
[0010] Preferably, the oocyte is a mouse oocyte.
[0011] As further preferred, the mouse strain is C57 strain, ICR strain or KM strain.
[0012] As further preferred, the age of the mice is 8 to 40 weeks.
[0013] As further preferred, the culture medium used for the in vitro culture is M16 culture medium.
[0014] Another object of the present application is to provide an oocyte to which electromagnetic pulses have been applied using the above method.
[0015] In general, the above technical solutions conceived by this application have the following technical advantages compared with the prior art:
[0016] 1. This application applies pulsed magnetic field to oocytes for the first time, establishing a new way to improve the maturation and development ability of oocytes, which can significantly improve the maturation and development ability of oocytes, thereby improving the normal development of follicles and generally improving the problem of decreased ovarian reserve function; in addition, this application uses electromagnetic field as a physical therapy, which is a non-invasive technology, greatly increasing the safety and effectiveness of its application;
[0017] 2. It has been verified that after being exposed to the magnetic field, various indicators of 40-week-old mice were improved, such as increased fertilization rate, increased mitochondrial membrane potential, increased number of mitochondria, lower proportion of abnormal spindle morphology, reduced reactive oxygen, and lower lysosomal vesicle density; among them, the in vitro blastocyst formation rate and apoptosis reached a level close to that of 8-week-old mice. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1a is the fertilization rate of in vitro fertilization in the examples and comparative examples of the present application;
[0019] Figure 1b It is a statistical chart of the percentage of development to the blastocyst stage after in vitro fertilization in the examples and comparative examples of the present application;
[0020] Figure 1c is the in vitro blastocyst formation rate of the complex after in vitro fertilization in the embodiment of the present application and the comparative example;
[0021] Figure 2aThe JC-1 staining of the examples and comparative examples of the present application shows the mitochondrial membrane potential of the oocyte;
[0022] Figure 2b It is a statistical diagram of mitochondrial membrane potential provided in the examples and comparative examples of the present application;
[0023] Figure 3a The Mito-Tracker staining provided in the examples and comparative examples of the present application shows the distribution and number of mitochondria in oocytes;
[0024] Figure 3b It is a statistical graph of mitochondrial fluorescence intensity provided in the examples and comparative examples of the present application;
[0025] Figure 4a It is a schematic diagram of the spindle morphology in the oocyte provided in the examples and comparative examples of the present application;
[0026] Figure 4b It is the statistics of the ratio of abnormal spindle morphology in oocytes provided in the examples and comparative examples of the present application;
[0027] Figure 5a It is a detection diagram of active oxygen level in oocytes provided by the examples and comparative examples of the present application;
[0028] Figure 5b It is the statistical result of active oxygen level provided by the examples and comparative examples of the present application;
[0029] Figure 6a This is the detection diagram of oocyte apoptosis determined by Annexin staining provided in the examples and comparative examples of the present application;
[0030] Figure 6b It is the statistical result of oocyte apoptosis provided by the examples and comparative examples of the present application;
[0031] Figure 7 The examples and comparative examples of the present application provide LysoTracker Green staining lysosome detection pictures;
[0032] Figure 8 It is the statistical result of lysosomal vesicle density of the examples and comparative examples of the present application. DETAILED DESCRIPTION
[0033] In order to make the purpose, technical solution and advantages of the present application more clearly understood, the present application is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application.
[0034] In the description of the present application, it should be understood that the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of the feature. In the description of the present application, "plurality" means two or more, unless otherwise clearly and specifically defined.
[0035] In addition, references throughout this specification to "one embodiment"; "one embodiment", "an example" or similar language indicate that a particular feature, structure, or characteristic described in conjunction with the embodiment is included in at least one embodiment of the present application. Thus, appearances of the phrase "in one embodiment"; "in one embodiment" and similar language throughout this specification may, but do not necessarily, all refer to the same embodiment.
[0036] The present application provides a method for applying electromagnetic pulses to oocytes cultured in vitro, comprising: applying electromagnetic pulses with a frequency of 1 to 100 Hz, an intensity of 1 to 10 mT, and a duration of 5 to 30 min to the oocytes in the germinal vesicle stage; in some embodiments, the frequency is preferably 30 to 60 Hz, the intensity is preferably 5 to 10 mT, and the duration is preferably 7 to 15 min. In some embodiments, the culture density of the oocytes cultured in vitro is 300 to 600 cells / ml; in other embodiments, the electromagnetic pulses are applied 1 to 10 times, and the application interval is 30 to 60 ms.
[0037] In some embodiments, the oocyte is a mammalian oocyte, such as a mouse oocyte of the C57, ICR or KM line, preferably a female oocyte of 8 to 40 weeks of age; the culture medium used during culture is preferably M16 culture medium.
[0038] The maturation and developmental abilities of oocytes to which electromagnetic pulses were applied using the above method were significantly improved.
[0039] The following are examples:
[0040] Comparative Example 1 Mouse Oocyte Acquisition and IVM (In Vitro Maturation) Culture
[0041] The oocytes involved in this embodiment are GV stage oocytes, which are obtained by in vitro culture, and the specific steps are as follows:
[0042] S1. Ovulation induction in mice: After newly acquired 40-week-old C57 female mice have adapted to the environment, 5-10 IU of pregnant mare serum gonadotropin (PMSG) are injected intraperitoneally according to their body weight.
[0043] S2. Preparation of culture droplets and pre-incubation: Prepare the droplet dish in advance and incubate in the incubator for more than 6 hours. Prepare one M2 cleaning dish and one egg poking dish for each mouse (2 ovaries) on average. Make 20μL droplets of IVM culture solution and cover them with mineral oil to prevent evaporation. Make one IVM culture dish for each group, and keep an extra IVM culture dish for standby. For the injection droplet dish, use M2 culture solution containing 2.5μM milrinone at 10μL per drop on the dish cover and cover with mineral oil.
[0044] S3. Mouse ovary dissection: After 46-48 hours, kill the mouse, cut the skin and muscle through the abdomen or back, find the ovarian fat pad under the kidney, pull out the ovarian tissue, puncture the cyst, separate the ovarian tissue and put it into the preheated M2 solution.
[0045] S4. Acquisition of cumulus-oocyte complex (COC): After cleaning off the blood adhering to the surface, puncture the follicle with a sterile syringe under a stereoscope to release the COC that looks like a poached egg.
[0046] S5. Obtaining oocytes at GV stage: melt the capillary pipette, pull it to a suitable diameter (about 100 μm), and manually break the needle. The broken needle must be flat before use to avoid scratching the oocyte. Use a mouth pipette to repeatedly blow and suck COC to remove granulosa cells, and obtain GV stage oocytes, which are stored in a solution including sodium bicarbonate: 2.101 g / L, phenol red: 0.0106 g / L, sodium pyruvate: 0.0363 g, and dextran glucose: 1.0 g / L. The cell density is adjusted to 500 cells / ml.
[0047] Comparative Example 2
[0048] Comparative Example 1 was repeated with the same steps, except that newly acquired 8-week-old C57 female mice were used in step S1.
[0049] Example 1
[0050] Comparative Example 1 was repeated with the same steps, except that after step S5, a magnetic field was applied once to the GV stage oocyte under the condition of a pulsed magnetic field of 1 mT for 10 min.
[0051] In this embodiment, the magnetic field facility uses the pulse magnetic field experimental device of Huazhong University of Science and Technology, which mainly includes: self-recovery fuse F; rectifier bridge (D1, D2, D3, D4); filter capacitor C1; energy storage capacitor C2; filter inductor L1; DC control switches S1, S2, S3, S4; freewheeling diodes D5, D6; magnet (R m is the magnet resistance, L m is the magnet inductance, C mis the magnet parasitic capacitance); current sensor CT; voltage sensor VT; temperature sensor TP; bidirectional transient suppression diode D8; controller.
[0052] Experimental results verification
[0053] Hereinafter, Example 1, Comparative Example 1 and Comparative Example 2 are verified by developmental ability, mitochondrial membrane potential and other aspects. In all the figures, Old represents Comparative Example 1, Young represents Comparative Example 2, and Old+PMF represents Example 1.
[0054] Example 2
[0055] Example 1 was repeated with the same steps, except that after step S5, the intensity of the pulse magnetic field was 10 mT.
[0056] Experimental results verification
[0057] Hereinafter, Example 1, Comparative Example 1 and Comparative Example 2 are verified by developmental ability, mitochondrial membrane potential and other aspects. In all the figures, Old represents Comparative Example 1, Young represents Comparative Example 2, and Old+PMF represents Example 1.
[0058] Verification Example 1 Effect of pulsed magnetic field on the developmental capacity of immature oocytes in aged mice
[0059] In order to observe the effect of pulsed magnetic field on the developmental ability of immature oocytes in aged mice, we selected two indicators: fertilization rate and blastocyst rate. The oocytes of Example 1, Example 2, Comparative Example 1, and Comparative Example 2 were cultured and fertilized in vitro respectively. The specific steps of in vitro fertilization are as follows:
[0060] S1. Preparation and pre-incubation of fertilization and culture droplets: Prepare the droplet dish in advance and incubate it in the incubator for more than 6 hours. Sperm activation drops are made into 50μL droplets with HTF solution. A line is drawn between the two drops with the smallest gun tip to form a dumbbell shape, which is covered with mineral oil to prevent evaporation. HTF fertilization solution and KSOM embryo culture solution are made into 20μL droplets, which are covered with mineral oil to prevent evaporation.
[0061] S2. Sperm activation: 12-week-old sexually mature and robust C57 male mice were selected and killed by cervical dislocation. The testicles were pulled out by laparotomy to find the epididymis and epididymal tail. The entire epididymal tail was cut off with scissors and placed in one sperm activation drop. It was placed in a 37°C incubator for 1 hour. The activated sperm could be seen swimming to the HTF drop on the other side.
[0062] S3. Sperm addition: Use a mouth pipette to absorb the activated sperm and add it to the oocyte droplets of Example 1, Comparative Example 1, and Comparative Example 2. The amount of sperm added is preferably such that the sperm can push the oocyte to move. After sperm addition is completed, the culture dish is placed in an incubator.
[0063] S4. Egg washing: 5 hours after sperm addition, the granulosa cells around the oocytes have been digested and fallen off. The sperm around the oocytes are slightly washed and then transferred to KSOM embryo culture medium (K+ Simplex Optimised Medium) for further culture.
[0064] S5. Embryo culture: Observe the two-cell formation rate the next day and observe the development of oocytes every day.
[0065] The results of in vitro fertilization are shown in Figure 1. Figure 1a The horizontal axis is the experimental grouping, the vertical axis is the percentage, and the numerical columns from left to right are the fertilization rate statistics of the comparative example 2, comparative example 1 and embodiment 1 groups respectively; Figure 1b It is a statistical chart of the percentage of oocytes in the three groups that developed to the blastocyst stage after fertilization; Figure 1c The in vitro blastocyst formation rates of three groups of oocyte complexes. It can be clearly observed that after being exposed to the magnetic field, the fertilization rate and blastocyst formation rate of immature oocytes of aged mice were significantly increased. The specific values are shown in Table 1:
[0066] Table 1 Effects of different intensity pulsed magnetic fields on the developmental capacity of immature oocytes in young mice
[0067]
[0068] Verification Example 2 Effect of pulsed magnetic field on mitochondrial membrane potential of aged mouse oocytes
[0069] The mitochondrial membrane potential of the oocytes of Example 1, Comparative Example 1 and Comparative Example 2 was detected by JC-1 staining method. The brief steps are as follows:
[0070] S1. Liquid preparation and incubation: add 200 μL JC-1 staining solution (the components are JC-1 (200×): ultrapure water: JC-1 staining buffer (5×) at a volume ratio of 1:160:40 and mix evenly, ...) to the first well of a 5-well plate, and add JC-1 washing solution (the components are JC-1 staining buffer (5×): distilled water at a volume ratio of 1:4 and mix evenly) to the second and third wells.
[0071] S2.JC-1 staining: Collect the oocytes at the end of culture with a mouth pipette, transfer them into JC-1 staining solution, incubate at 37℃ for 20min, and wash twice in JC-1 washing solution to remove the dye particles adhered to the zona pellucida of the oocytes.
[0072] S3. Microscopic examination: Prepare 5 μL microdrops with IVM medium in a confocal dish and cover with mineral oil to prevent evaporation. Transfer the oocytes into the microdrops and observe and photograph them under a confocal microscope.
[0073] Figure 2aJC-1 staining shows the mitochondrial membrane potential of oocytes. J-aggregates refers to the staining effect of JC-1 monomers after aggregation to form polymers, which can produce red fluorescence; J-monomer refers to the staining effect of non-aggregated JC-1 monomers, which can produce green fluorescence; Merge refers to the merged fluorescence image of JC-1 polymers, monomers and nuclear staining; Figure 2b It is a statistical diagram of mitochondrial membrane potential; it can be seen that compared with Comparative Example 1, the mitochondrial membrane potential of the oocytes in Example 1 is increased.
[0074] Verification Example 3 Effect of pulsed magnetic field on the number of mitochondria in oocytes of aged mice
[0075] The mitochondrial fluorescence probe method was used to detect the distribution of mitochondria in the oocytes of Example 1, Comparative Example 1 and Comparative Example 2, and the specific steps were as follows:
[0076] S1. Solution preparation and incubation: Add mitochondrial fluorescent probe staining solution to the first well of a 5-well plate.
[0077] S2. Probe staining: Collect the oocytes at the end of culture with a mouth pipette, transfer them into mitochondrial fluorescent probe staining solution, and incubate at 37℃ for 20-30min.
[0078] S3. Microscopic examination: Prepare 5 μL microdrops with IVM medium in a confocal dish and cover with mineral oil to prevent evaporation. Transfer the oocytes into the microdrops and observe and photograph them under a confocal microscope.
[0079] Figure 3a Mito-Tracker staining shows the distribution and number of mitochondria in oocytes, where Mitotracker represents the fluorescent staining image of mitochondria in oocytes, Hoechst represents the fluorescent staining image of nuclei, and Merge represents the merged fluorescent image of mitochondria and nuclei; Figure 3b This is a statistical graph of mitochondrial fluorescence intensity provided in the examples of this application; as can be seen from the figure, MitoTracker Red stained mitochondria show that mitochondria in young mouse oocytes are evenly distributed in the cytoplasm and accumulate around the spindle. However, aging destroys this distribution pattern of mitochondria, showing fading of signals in the cytoplasm and loss of aggregation around chromosomes, which can be rescued to a certain extent by magnetic fields.
[0080] Compared with the young mice in Comparative Example 2, the oocytes of the aged mice in Comparative Example 1 had a higher proportion of disorganized spindles, misaligned chromosomes, and incorrect attachment of centromeres and microtubules. After the magnetic field was applied, the spindle abnormality rate of Example 1 was significantly reduced.
[0081] Verification Example 4 Effects of pulsed magnetic field on spindles in aged mice
[0082] Immunofluorescence was used to detect the spindle morphology of the oocytes in Example 1, Comparative Example 1 and Comparative Example 2. All steps of immunofluorescence staining (IF) of oocytes were completed under a stereomicroscope. The oocytes were placed in a 96-well plate or a 5-well culture dish, and the oocytes were transferred using a mouth pipette. The specific steps are as follows:
[0083] S1. Fixation: Fix oocytes of various stages in 4% PFA fixative and incubate at room temperature for 10 min.
[0084] S2. Membrane permeabilization and blocking: Depending on the subsequent incubation antibodies, incubate in cell membrane permeabilization buffer for 1 to 2 hours and wash three times in blocking buffer.
[0085] S3. Primary antibody incubation: Transfer oocytes into primary antibody and incubate overnight at 4°C.
[0086] S4. Secondary antibody incubation: Wash the oocytes three times with blocking solution in a dark room, then transfer to fluorescent secondary antibody and incubate at room temperature for 1 hour.
[0087] S5. DAPI counterstaining: Wash the oocytes after secondary antibody incubation three times and transfer them to DAPI solution for 5-10 minutes. Prepare antifade droplets in the confocal dish, about 5 μL / drop, transfer the oocytes into the droplets, and cover with 1 mL of mineral oil.
[0088] Figure 4a 1 is a schematic diagram of the spindle morphology in the oocyte provided in the embodiment of the present application, wherein α-tubin represents the oocyte spindle fluorescence staining, DAPI represents the chromatin fluorescence staining, and Merge represents the merged fluorescence image; Figure 4b It is a statistical diagram of the ratio of abnormal spindle morphology in three groups of oocytes provided in the examples of the present application; as can be seen from the figure, the fluorescence intensity was analyzed after staining with an active oxygen probe, and the results showed that the magnetic field rescued the increase in the active oxygen level in oocytes caused by aging.
[0089] Verification Example 5: Detection of reactive oxygen species levels in oocytes
[0090] Oocyte reactive oxygen species (ROS) The levels of oocyte reactive oxygen species in Example 1, Comparative Example 1 and Comparative Example 2 were detected, and the specific steps were as follows:
[0091] S1. Liquid preparation and incubation: Add 0.5 mL of DMEM to the first, second, fourth, and fifth wells of a 5-well plate, and add 200 μL of reactive oxygen species staining solution to the third well.
[0092] S2. Reactive oxygen species staining: Collect oocytes at the end of culture with a mouth pipette, wash twice in DMEM, transfer to reactive oxygen species staining solution, incubate at 37°C for 20 min, wash twice in DMEM, and remove excess probe.
[0093] S3. Microscopic examination: Prepare 5 μL microdrops with IVM medium in a confocal dish and cover with mineral oil to prevent evaporation. Transfer the oocytes into the microdrops and observe and photograph them under a confocal microscope.
[0094] Figure 5a It is the detection of reactive oxygen levels in oocytes provided in the examples of the present application, wherein ROS represents reactive oxygen staining in oocytes, Brightfield represents nuclear staining, and Merge represents a fluorescent merged image; Figure 5b It is the statistics of active oxygen levels provided in the examples of the present application; it can be seen from the figure that the active oxygen content in the oocytes of the young group of comparison example 2 is lower, the active oxygen content in the oocytes of the old group of comparison example 1 is significantly increased, and the active oxygen level in example 1 has been significantly restored after the action of the magnetic field.
[0095] Verification Example 6 Detection of early apoptosis level in oocytes
[0096] Annexin V-FITC staining was used to detect the oocytes of Example 1, Comparative Example 1 and Comparative Example 2. The brief steps are as follows:
[0097] S1. Liquid preparation and incubation: Add 0.5 mL of DPBS to the first, second, fourth, and fifth wells of a 5-well plate, and add 200 μL of Annexin V-FITC staining solution to the third well.
[0098] S2. Staining: Collect the oocytes at the end of culture with a mouth pipette, wash twice with DPBS, transfer to staining solution, and incubate at room temperature in a dark room for 20 minutes.
[0099] S3. Microscopic examination: Wash the stained oocytes twice in DPBS. Prepare a 5 μL droplet of Annexin V-FITC conjugate in a confocal dish and cover with mineral oil to prevent evaporation. Transfer the oocytes into the droplet and observe and photograph under a confocal microscope.
[0100] Figure 6a Annexin staining provided in the examples of the present application is used to determine the apoptosis of oocytes, wherein Annexin-V represents the oocyte Annexin-FITC fluorescence image, Brightfield represents the nuclear fluorescence image, and Merge represents the merged fluorescence image; Figure 6b It is a statistical diagram of oocyte apoptosis provided by the examples and comparative examples of the present application; as can be seen from the figure, compared with comparative example 1, example 1 after the action of the magnetic field reduces the level of early apoptosis to a certain extent.
[0101] Verification Example 7 Lysosome staining detection
[0102] Figure 7It is the LysoTracker Green staining lysosome detection provided in the embodiment of the present application, wherein Lyso-Tracker represents the oocyte lysosome fluorescence image, Hoechst represents the nuclear fluorescence image, and Merge represents the merged fluorescence image; Figure 8 is the fluorescence intensity of Lyso-Tracker; as can be seen from the figure, the magnetic field significantly reduces the density of lysosomal vesicles in aged mouse oocytes.
[0103] Through the above verification examples, it can be seen that after the magnetic field, all indicators of 40-week-old mice have been improved, such as increased fertilization rate, increased mitochondrial membrane potential, increased number of mitochondria, lower proportion of abnormal spindles, reduced reactive oxygen, and lower lysosomal vesicle density; the in vitro blastocyst formation rate and apoptosis have reached levels close to those of 8-week-old mice. The above improvement effects can be achieved by adjusting the electromagnetic pulse frequency between 1 and 100 Hz, the intensity between 1 and 10 mT, and the duration between 5 and 30 min; at the same time, we adjusted the culture density of oocytes between 300 and 600 / ml, and tried to apply 2 to 10 electromagnetic pulses to the same group of oocytes, each with an interval of 30 to 60 ms, which can achieve the above improvement effects, and the above improvement effects exist for mice aged 8 to 40 weeks.
[0104] The tests of Verification Examples 2 to 7 on Example 2 also showed the same effects as those of Example 1.
[0105] It will be easily understood by those skilled in the art that the above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present application shall be included in the scope of protection of the present application.
Claims
1. A method for applying electromagnetic pulses to oocytes cultured in vitro, characterized in that: include: Electromagnetic pulses with a frequency of 1 to 100 Hz, an intensity of 1 to 10 mT and a duration of 5 to 20 minutes are applied to the oocytes in the germinal vesicle stage.
2. The method according to claim 1, characterized in that The culture density of the in vitro cultured oocytes is 300 to 600 oocytes / ml.
3. The method according to claim 1, characterized in that The electromagnetic pulses are applied 1 to 10 times, and the application interval is 30 to 60 ms.
4. The method according to claim 1, characterized in that The oocyte is a mouse oocyte.
5. The method according to claim 4, characterized in that The strain of the mice is C57, ICR or KM.
6. The method according to claim 4, characterized in that The age of the mice ranged from 8 to 40 weeks.
7. The method according to claim 4, characterized in that The culture medium used for the in vitro culture is M16 culture medium.
8. An oocyte to which electromagnetic pulses have been applied using the method according to any one of claims 1 to 7.
Citation Information
Patent Citations
Oocyte cryopreservation solution and method for preserving oocytes at low temperature through magnetic field
CN113367124A
Physical method for improving granular cell proliferation activity
CN116716237A
Cited By
Method for improving freeze-thaw ovarian function by adopting mT-level pulsed magnetic field
CN121699848A
